RecruitingPhase 3NCT06022146
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Huashan Hospital
- Intervention
- isoniazid and rifapentine(drug)
- Enrollment
- 3520 enrolled
- Eligibility
- 13 years · All sexes
- Timeline
- 2023 – 2026
Study locations (30)
- People's Hospital of Hezhang, Bijie, Guizhou, China
- People's Hospital of Qianxi, Bijie, Guizhou, China
- People's Hospital of Weining, Bijie, Guizhou, China
- People's Hospital of Zhijin, Bijie, Guizhou, China
- People's Hospital of Daozhen Klau and Hmong autonomous county, Daozhen Klau and Hmong Autonomous County in Zun'yi, Guizhou, China
- Liuzhi Special District, Liupanshui, Guizhou, China
- People's Hospital of Panzhou, Liupanshui, Guizhou, China
- People's Hospital of Shuicheng District, Liupanshui City, Liupanshui, Guizhou, China
- Second People's Hospital of Liupanshui City, Liupanshui, Guizhou, China
- Third People's Hospital of Liupanshui, Liupanshui, Guizhou, China
- People's Hospital of Cengong, Qiandongnan Miao and Dong Autonomous Prefecture, Guizhou, China
- People's Hospital of Congjiang, Qiandongnan Miao and Dong Autonomous Prefecture, Guizhou, China
- First People's Hospital of Kaili, Qiandongnan Miao and Dong Autonomous Region, Guizhou, China
- People's Hospital of Danzhai, Qiandongnan Miao and Dong Autonomous Region, Guizhou, China
- People's Hospital of Huangping, Qiandongnan Miao and Dong Autonomous Region, Guizhou, China
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06022146 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet
- RECRUITINGPHASE3NCT06497465Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentJohns Hopkins University
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine